Medical News

RSS

Study reveals true effects of malaria on African generations

Almost a third of cerebral malaria survivors developed epilepsy or other behavioral disorders in the most comprehensive study to date of the disease in African children, solidifying the link between malaria and neuropsychiatric disorders that affect hundreds of thousands of children.

17 Nov 2010

Faster FDA action against alcoholic energy drinks needed

Alcoholic energy drinks have been making national headlines and four states to date have banned their sale following reports of blackouts and unsafe behaviors, especially among college students. These actions are encouraging to Wake Forest University Baptist Medical Center emergency physician Mary Claire O'Brien, M.D., who conducted groundbreaking research into the dangers of the manufactured drinks.

17 Nov 2010

Specific brain changes suggest new therapeutic targets for Alzheimer's disease

New studies identify brain changes in people with Alzheimer's disease. The results give researchers a greater understanding of the disease and may help at-risk individuals by improving early detection. New animal research also shows a novel approach to Alzheimer's vaccine design that may avoid dangerous side effects. These new results were reported at Neuroscience 2010, the annual meeting of the Society for Neuroscience and the world's largest source of emerging news on brain science and health.

17 Nov 2010

CDH Proton Center commences treatment with IBA's Proteus 235 proton delivery system

IBA (Ion Beam Applications S.A.) and ProCure Treatment Centers, Inc., (ProCure) announced today that the CDH Proton Center, A ProCure Center, located outside Chicago, recently delivered proton radiation treatment to its first patients using IBA's Proteus 235 proton delivery system. It took only 24 months to build the facility, install the equipment and treat the first patient, setting a new world record in bringing this important technology to patients who could benefit.

17 Nov 2010

PrecisionMed enrolls first subject in Multiple Sclerosis Registry

PrecisionMed Inc. today announced at the Society for Neuroscience annual meeting in San Diego, enrollment of the first subject into the PrecisionMed Multiple Sclerosis (MS) Registry. The PrecisionMed MS Registry is a biological sample bank of DNA and serial RNA, CSF, serum and plasma associated with serial clinical testing utilizing PrecisionMed's clinical data procurement and storage capabilities.

17 Nov 2010

Noninvasive method to determine estrogen levels in infants through diapers

With the help of babies and more than 5,000 of their diapers, Emory University researchers have developed an accurate, noninvasive method to determine estrogen levels in infants.

17 Nov 2010

New OncoMap technique can detect point mutation in ovarian cancer

Researchers have shown that point mutations mis-spellings in a single letter of genetic code that drive the onset and growth of cancer cells can be detected successfully in advanced ovarian cancer using a technique called OncoMap. The finding opens the way for personalised medicine in which every patient could have their tumour screened, specific mutations identified, and the appropriate drug chosen to target the mutation and halt the growth of their cancer.

17 Nov 2010

John Muir Health opens The Hofmann Family Patient Care Tower

Today, John Muir Health opened the doors of The Hofmann Family Patient Care Tower at John Muir Medical Center, Concord, which includes 120 new private rooms (61 open with 59 shelled for future use), a new Cardiovascular Institute and a new Emergency Department. The 172,000 square foot facility, which took three years and $212 million to complete, also features state-of-the-art technology and a patient-focused, healing environment.

17 Nov 2010

HCI unveils next-generation technology platform for fraud, waste, and abuse prevention and detection

HealthCare Insight (HCI) today unveiled Nucleus™, a next-generation technology platform for fraud, waste, and abuse prevention and detection, at the Annual Training Conference & Anti-Fraud Expo of the National Healthcare Anti-Fraud Association (NHCAA). The Nucleus application features advanced analytics, comprehensive risk scoring, and a customizable interface to help insurers stop fraud before medical claims are paid.

17 Nov 2010

Alkermes's ALKS 33 drug candidate offers potential treatment for multiple disease indications

Alkermes, Inc. today announced the presentation of promising preclinical results for its proprietary opioid modulator, ALKS 33, showing the drug candidate's potential in multiple disease indications.

17 Nov 2010

Combination doxorubicin-sorafenib treatment improves survival in patients with inoperable advanced liver cancer

Treatment of inoperable advanced liver cancer with the agent doxorubicin (routinely used to treat this condition) in addition to the agent sorafenib resulted in greater overall survival and progression-free survival, compared to patients who received treatment with doxorubicin alone, according to a study in the November 17 issue of JAMA.

17 Nov 2010

Eisai enters strategic drug discovery collaboration with FORMA Therapeutics

Eisai Inc., the U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd., and FORMA Therapeutics announced today that the two companies have signed a strategic drug discovery collaboration.

17 Nov 2010

Health officials gather in Uruguay to discuss WHO anti-smoking treaty

"As sales to developing nations become ever more important to giant tobacco companies, they are stepping up efforts around the world to fight tough restrictions on the marketing of cigarettes," the New York Times reports in an article ahead of a conference in Punta del Este, Uruguay, which began on Monday. At the conference health officials are debating guidelines to enforce a global anti-smoking treaty known as the Framework Convention on Tobacco Control (FCTC) (Wilson, 11/13).

17 Nov 2010

Enzon presents data on three investigational mRNA antagonists at EORTC-NCI-AACR Symposium

Enzon Pharmaceuticals, Inc. today presented data from preclinical studies of three investigational messenger RNA (mRNA) antagonists. These antagonists are based on the locked nucleic acid (LNA) technology platform targets licensed from Santaris Pharma A/S.

17 Nov 2010

St. Jude Medical and ZONARE enter partnership in ultrasound imaging

St. Jude Medical, Inc., a global medical device company and ZONARE Medical Systems, a leading provider of premium ultrasound systems, today announced they have entered into a development and marketing agreement. Under this agreement, the companies will combine the St. Jude Medical intracardiac echocardiography (ICE) catheter and the ZONARE z.one Convertible Ultrasound system technology, and co-market an ultrasound system for intracardiac (inside the heart) imaging.

17 Nov 2010

Metallic particles in smoke from fireworks affect human health

The metallic particles in the smoke emitted by fireworks pose a health risk, particularly to people who suffer from asthma. This is the conclusion of a study led by researchers from the Institute of Environmental Assessment and Water Research (IDAEA-CSIC), published this week in the Journal of Hazardous Materials.

17 Nov 2010

TRITON–TIMI 38 substudy shows prasugrel reduces overall mortality rate in ACS patients

New results from an observational substudy from TRITON–TIMI 38 presented today at the American Heart Association (AHA) Scientific Sessions annual meeting showed that patients treated with Efient/Effient (prasugrel) prior to coronary artery bypass graft surgery (CABG) had a reduced overall mortality rate compared to patients treated with Plavix (clopidogrel)

17 Nov 2010

One in seven Medicare patients harmed by problems in hospital, HHS report finds

The New York Times: "One of every seven Medicare beneficiaries who is hospitalized is harmed as a result of problems with the medical care there, according to a new study [.pdf] from the Office of Inspector General for the Department of Health and Human Services. The study said unexpected adverse events added at least $4.4 billion a year to government health costs and contributed to the deaths of about 180,000 patients a year."

17 Nov 2010

Chimerix’s lipid-conjugated drugs reduces nephrotoxicity: Study

Scientists from Chimerix, Inc. today presented in vitro data demonstrating that the company's lipid-conjugated drugs, CMX001 and CMX157, are not substrates for the human Organic Anion Transporters (hOATs) and thus have significantly reduced potential to cause nephrotoxicity via this mechanism.

17 Nov 2010

NDSsi selected by PENTAX as preferred partner for medical visualization solutions

The US-market leader in surgical displays, NDS Surgical Imaging (NDSsi) has been selected by PENTAX Europe GmbH as the preferred partner and supplier of medical visualization solutions. The agreement signals a Europe-wide expansion in the relationship between two companies renowned for technology innovation.

17 Nov 2010

Medical News

Study reveals true effects of malaria on African generations

Faster FDA action against alcoholic energy drinks needed

Specific brain changes suggest new therapeutic targets for Alzheimer's disease

CDH Proton Center commences treatment with IBA's Proteus 235 proton delivery system

PrecisionMed enrolls first subject in Multiple Sclerosis Registry

Noninvasive method to determine estrogen levels in infants through diapers

New OncoMap technique can detect point mutation in ovarian cancer

John Muir Health opens The Hofmann Family Patient Care Tower

HCI unveils next-generation technology platform for fraud, waste, and abuse prevention and detection

Alkermes's ALKS 33 drug candidate offers potential treatment for multiple disease indications

Combination doxorubicin-sorafenib treatment improves survival in patients with inoperable advanced liver cancer

Eisai enters strategic drug discovery collaboration with FORMA Therapeutics

Health officials gather in Uruguay to discuss WHO anti-smoking treaty

Enzon presents data on three investigational mRNA antagonists at EORTC-NCI-AACR Symposium

St. Jude Medical and ZONARE enter partnership in ultrasound imaging

Metallic particles in smoke from fireworks affect human health

TRITON–TIMI 38 substudy shows prasugrel reduces overall mortality rate in ACS patients

One in seven Medicare patients harmed by problems in hospital, HHS report finds

Chimerix’s lipid-conjugated drugs reduces nephrotoxicity: Study

NDSsi selected by PENTAX as preferred partner for medical visualization solutions

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News